arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Microbot Medical Inc.

MBOT Health Care Biotechnology: Biological Products (No Diagnostic Substances)
$0.99
▲ +5.0% Today
as of Oct 23, 12:19 ET
Last 30 days -32.43% Sep 14 → Oct 23
$0.90 $1.05 $1.20 $1.34 $1.49 Sep 14 Sep 22 Sep 30 Oct 07 Oct 15 Oct 23
Open
$0.94
High
$0.96
Low
$0.93
Volume
$296,711
Avg Vol
$2M
Mkt Cap
$81M
P/E (TTM)
—
Beta
—
52w High
$2.86
52w Low
$0.93
Div Yield
—
Shares Out
$67M

Recent Press Releases & News last 60 days · 3 items

Oct 20 · 12:30 PR GlobeNewswire
Microbot Medical® Granted Multiple New Patents, Further Strengthening Its Global Intellectual Property Portfolio
Oct 6 · 12:30 PR GlobeNewswire
Microbot Medical® and Medtechnica Ltd. Enter into Three-Year Exclusive Distribution Agreement in Israel
Sep 25 · 21:30 PR GlobeNewswire
Microbot Medical® Highlights Growth Strategy

MBOT earnings at a glance

The options market is pricing a move of about ±25.9% after the report, a range of roughly $0.73 to $1.25 from today's $0.99. Over its last 2 reports the stock rose the next day 1 time and fell 1, moving ±2.1% on average; after the most recent report on May 13, 2026 it moved -0.9%. That means options currently expect more movement than MBOT has typically delivered. MBOT beat the consensus EPS estimate in 2 of its last 4 reported quarters. Implied volatility is currently 124%. The share price of $0.99 sits near its 52-week low.

More Health Care stocks · All stocks · Earnings calendar

Overview

52-week range
$0.93
$2.86
3% of range
Avg surprise (last 4)
+8.6%
Avg reaction (last 2)
+1.2%
50% positive
Latest IV / EM
124%
EM ±25.9% · $2 · Oct 16

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.36$-0.28$-0.20$-0.13$-0.05 Actual $-0.36Actual $-0.25Actual $-0.21Actual $-0.17Actual $-0.17Actual $-0.20Actual $-0.08Est $-0.13Actual $-0.10Est $-0.08Actual $-0.07Est $-0.06Actual $-0.05Est $-0.08Actual $-0.08 MarJunSepMarJunSepMar/2025Jun/2025Sep/2025Mar/2026Jun
Revenue vs Net Income Revenue Net income
$-6M$-4M$-3M$-1M$253,050 Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $-0.08 — — — — financials
Wed May 13, 2026Mar/2026 $-0.05 $-0.08 +37.5% +37.5% -0.9% earnings
Wed Nov 12, 2025Sep/2025 $-0.07 $-0.06 -16.7% — — earnings
Tue Aug 12, 2025Jun/2025 $-0.10 $-0.08 -25.0% — — earnings
Wed May 14, 2025Mar/2025 $-0.08 $-0.13 +38.5% — +3.4% earnings
Mon Sep 30, 2024Sep 2024 $-0.20 — — — — financials
Sun Jun 30, 2024Jun 2024 $-0.17 — — — — financials
Sun Mar 31, 2024Mar 2024 $-0.17 — — — — financials
Sat Sep 30, 2023Sep 2023 $-0.21 — — — — financials
Fri Jun 30, 2023Jun 2023 $-0.25 — — — — financials
Fri Mar 31, 2023Mar 2023 $-0.36 — — — — financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$241,000$105,000——————
Cost of revenue$884,000$103,000——————
Gross profit$-643,000$2,000——————
Operating income$-6M$-4M—$-4M$-4M$-3M—$-3M
Net income$-6M$-4M—$-4M$-4M$-3M—$-3M
EPS (diluted)$-0.08$-0.05—$-0.07$-0.10$-0.08—$-0.20

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$3M$4M$4M$7M$4M$3M$3M$479,000
Inventory$3M$2M$584,000—————
Total current assets$72M$77M$80M$81M$33M$31M$6M$5M
Total assets$73M$78M$82M$82M$33M$31M$6M$5M
Long-term debt————————
Total liabilities$4M$4M$4M$4M$3M$2M$3M$1M
Total equity$69M$74M$78M$78M$30M$29M$4M$4M

Implied volatility — last 90 days

35%216%397%578%758% Jun 07 — IV 147% · EM ±20.4%Jun 08 — IV 156% · EM ±20.6%Jun 09 — IV 143% · EM ±17.9%Jun 10 — IV 166% · EM ±19.6%Jun 11 — IV 149% · EM ±16.5%Jun 12 — IV 220% · EM ±22.5%Jun 15 — IV 285% · EM ±20.6%Jun 16 — IV 372% · EM ±22.0%Jun 17 — IV 382% · EM ±16.0%Jun 19 — IV 128% · EM ±28.2%Jun 22 — IV 136% · EM ±28.4%Jun 23 — IV 201% · EM ±41.2%Jun 24 — IV 180% · EM ±36.1%Jun 25 — IV 109% · EM ±21.3%Jun 26 — IV 103% · EM ±19.7%Jun 29 — IV 90% · EM ±16.0%Jun 30 — IV 74% · EM ±12.8%Jul 01 — IV 171% · EM ±28.6%Jul 02 — IV 80% · EM ±13.0%Jul 03 — IV 84% · EM ±13.1%Jul 06 — IV 94% · EM ±13.0%Jul 07 — IV 100% · EM ±13.2%Jul 08 — IV 64% · EM ±8.0%Jul 09 — IV 310% · EM ±36.6%Jul 10 — IV 168% · EM ±18.5%Jul 13 — IV 221% · EM ±18.4%Jul 14 — IV 628% · EM ±45.5%Jul 15 — IV 273% · EM ±16.1%Jul 20 — IV 82% · EM ±19.4%Jul 21 — IV 36% · EM ±8.3%Jul 22 — IV 37% · EM ±8.5%Jul 23 — IV 38% · EM ±8.5%Jul 24 — IV 106% · EM ±23.4%Jul 27 — IV 96% · EM ±20.1%Jul 28 — IV 202% · EM ±41.4%Jul 30 — IV 147% · EM ±28.7%Jul 31 — IV 152% · EM ±29.1%Aug 03 — IV 175% · EM ±31.1%Aug 04 — IV 144% · EM ±24.7%Aug 05 — IV 97% · EM ±16.2%Aug 06 — IV 137% · EM ±22.2%Aug 07 — IV 51% · EM ±7.9%Aug 10 — IV 112% · EM ±15.5%Aug 11 — IV 220% · EM ±29.0%Aug 12 — IV 297% · EM ±37.2%Aug 24 — IV 89% · EM ±18.6%Aug 26 — IV 66% · EM ±13.1%Aug 27 — IV 68% · EM ±13.3%Aug 28 — IV 70% · EM ±13.3%Aug 31 — IV 57% · EM ±10.1%Sep 03 — IV 86% · EM ±13.9%Sep 04 — IV 85% · EM ±13.4%Sep 10 — IV 290% · EM ±34.2%Sep 11 — IV 94% · EM ±10.3%Sep 14 — IV 125% · EM ±10.5%Sep 15 — IV 192% · EM ±13.9%Sep 16 — IV 235% · EM ±13.9%Sep 17 — IV 759% · EM ±31.7%Sep 21 — IV 124% · EM ±25.9%

Sector peers

PTHS
Pelthos Therapeutics Inc.
$78M $18.25-2.4%
CRDF
Cardiff Oncology, Inc.
$85M $0.90-4.6%
ATRA
Atara Biotherapeutics, Inc.
$85M $9.10-2.7%
NMRA
Neumora Therapeutics, Inc.
$88M $0.38-9.7%
CGTX
Cognition Therapeutics, Inc.
$89M $0.72-3.8%
KLRS
Kalaris Therapeutics, Inc.
$68M $1.98-1.8%

MBOT earnings FAQ

What is MBOT's expected move for earnings?

Options currently price a move of about ±25.9%, or $0.26 per share either way from $0.99.

How does MBOT stock usually react to earnings?

Across the last 2 reports the average next-day move was ±2.1%, up 1 times and down 1 times.

What is MBOT's implied volatility?

MBOT's at-the-money implied volatility is about 124% based on the latest options snapshot.

View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in